T Boujan1, U Neuberger1, J Pfaff1, S Nagel2, C Herweh1, M Bendszus1, M A Möhlenbruch3. 1. From the Departments of Neuroradiology (T.B., U.N., J.P., C.H., M.B., M.M.). 2. Neurology (S.N.), University of Heidelberg Medical Center, Heidelberg, Germany. 3. From the Departments of Neuroradiology (T.B., U.N., J.P., C.H., M.B., M.M.) markus.moehlenbruch@med.uni-heidelberg.de.
Abstract
BACKGROUND AND PURPOSE: Vessel imaging in acute ischemic stroke is essential to select patients with large-vessel occlusion for mechanical thrombectomy. Our aim was to compare the diagnostic accuracy of time-of-flight MR angiography and contrast-enhanced MR angiography for identification of vessel occlusion and collateral status in acute ischemic stroke. MATERIALS AND METHODS: One hundred twenty-three patients with stroke with large-vessel occlusion before thrombectomy were included in this retrospective study. Before thrombectomy, 3T MR imaging, including conventional 3D TOF-MRA of the intracranial arteries and contrast-enhanced MRA of intra- and extracranial arteries, was performed. Both techniques were assessed independently by 2 neuroradiologists for location of the occlusion, imaging quality, and collateral status. Findings were compared, with subsequent DSA as the reference standard. RESULTS: Both techniques had good interrater agreement of κ = 0.74 (95% CI, 0.66-0.83) for TOF-MRA and κ = 0.72 (95% CI, 0.63-0.80) for contrast-enhanced MRA. Occlusion localization differed significantly on TOF-MRA compared with DSA (P < .001), while no significant difference was observed between DSA and contrast-enhanced MRA (P = .75). Assessment of collaterals showed very good agreement between contrast-enhanced MRA and DSA (94.9% with P = .25), but only fair agreement between TOF-MRA and DSA (23.2% with P < .001). CONCLUSIONS: Contrast-enhanced MRA offers better diagnostic accuracy than TOF-MRA in acute ischemic stroke. Contrast-enhanced MRA was superior in localizing vessel occlusion within a shorter acquisition time while providing a larger coverage, including extracranial vessels, and a more accurate assessment of collateral status. These results support inclusion of contrast-enhanced MRA in acute stroke MR imaging, perhaps making TOF-MRA superfluous.
BACKGROUND AND PURPOSE: Vessel imaging in acute ischemic stroke is essential to select patients with large-vessel occlusion for mechanical thrombectomy. Our aim was to compare the diagnostic accuracy of time-of-flight MR angiography and contrast-enhanced MR angiography for identification of vessel occlusion and collateral status in acute ischemic stroke. MATERIALS AND METHODS: One hundred twenty-three patients with stroke with large-vessel occlusion before thrombectomy were included in this retrospective study. Before thrombectomy, 3T MR imaging, including conventional 3D TOF-MRA of the intracranial arteries and contrast-enhanced MRA of intra- and extracranial arteries, was performed. Both techniques were assessed independently by 2 neuroradiologists for location of the occlusion, imaging quality, and collateral status. Findings were compared, with subsequent DSA as the reference standard. RESULTS: Both techniques had good interrater agreement of κ = 0.74 (95% CI, 0.66-0.83) for TOF-MRA and κ = 0.72 (95% CI, 0.63-0.80) for contrast-enhanced MRA. Occlusion localization differed significantly on TOF-MRA compared with DSA (P < .001), while no significant difference was observed between DSA and contrast-enhanced MRA (P = .75). Assessment of collaterals showed very good agreement between contrast-enhanced MRA and DSA (94.9% with P = .25), but only fair agreement between TOF-MRA and DSA (23.2% with P < .001). CONCLUSIONS: Contrast-enhanced MRA offers better diagnostic accuracy than TOF-MRA in acute ischemic stroke. Contrast-enhanced MRA was superior in localizing vessel occlusion within a shorter acquisition time while providing a larger coverage, including extracranial vessels, and a more accurate assessment of collateral status. These results support inclusion of contrast-enhanced MRA in acute stroke MR imaging, perhaps making TOF-MRA superfluous.
Authors: Ioannis Koktzoglou; Emily A Aherne; Matthew T Walker; Joel R Meyer; Robert R Edelman Journal: J Magn Reson Imaging Date: 2019-05-11 Impact factor: 4.813
Authors: Ulrike Cornelia Isabel Hoyer; Simon Lennartz; Nuran Abdullayev; Florian Fichter; Stephanie T Jünger; Lukas Goertz; Kai Roman Laukamp; Roman Johannes Gertz; Jan-Peter Grunz; Christopher Hohmann; David Maintz; Thorsten Persigehl; Christoph Kabbasch; Jan Borggrefe; Kilian Weiss; Lenhard Pennig Journal: Quant Imaging Med Surg Date: 2022-07
Authors: Lenhard Pennig; Christoph Kabbasch; Ulrike Cornelia Isabel Hoyer; Simon Lennartz; David Zopfs; Lukas Goertz; Kai Roman Laukamp; Anton Wagner; Jan-Peter Grunz; Jonas Doerner; Thorsten Persigehl; Kilian Weiss; Jan Borggrefe Journal: Clin Neuroradiol Date: 2020-10-07 Impact factor: 3.649